相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations
Nihal El Rouby et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
FAM201A, a long noncoding RNA potentially associated with atrial fibrillation identified by ceRNA network analyses and WGCNA
Xi Chen et al.
BMC MEDICAL GENOMICS (2022)
SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population
Qiufen Xie et al.
FRONTIERS IN GENETICS (2022)
A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients
Innocent G. G. Asiimwe et al.
FRONTIERS IN PHARMACOLOGY (2022)
Database resources of the National Center for Biotechnology Information
Eric W. Sayers et al.
NUCLEIC ACIDS RESEARCH (2021)
FAM201A knockdown inhibits proliferation and invasion of lung adenocarcinoma cells by regulating miR-7515/GLO1 axis
Jun Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Genome-wide association studies
Emil Uffelmann et al.
NATURE REVIEWS METHODS PRIMERS (2021)
Benefits and limitations of genome-wide association studies
Vivian Tam et al.
NATURE REVIEWS GENETICS (2019)
Prenatal chromosomal microarray analysis in fetuses with congenital heart disease: a prospective cohort study
Yan Wang et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
FGF2 and FAM201A affect the development of osteonecrosis of the femoral head after femoral neck fracture
Gangyong Huang et al.
GENE (2018)
Genetics of Atrial Fibrillation: State of the Art in 2017
Diane Fatkin et al.
HEART LUNG AND CIRCULATION (2017)
Warfarin Pharmacogenomics in Diverse Populations
Justin B. Kaye et al.
PHARMACOTHERAPY (2017)
Genetics and Genomics of Congenital Heart Disease
Samir Zaidi et al.
CIRCULATION RESEARCH (2017)
HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease
Lucas D. Ward et al.
NUCLEIC ACIDS RESEARCH (2016)
Atrial Septal Defects and Cardioembolic Strokes
Michelle Leppert et al.
CARDIOLOGY CLINICS (2016)
Ischemic Stroke in Children and Young Adults With Congenital Heart Disease
Zacharias Mandalenakis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence
Brooke L. Fridley et al.
FRONTIERS IN GENETICS (2016)
The Genotype-Tissue Expression (GTEx) Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
Genome-wide association study of warfarin maintenance dose in a Brazilian sample
Esteban J. Parra et al.
PHARMACOGENOMICS (2015)
The Genotype-Tissue Expression (GTEx) Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
NKX2-6 mutation predisposes to familial atrial fibrillation
Jun Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Expanding the mutation spectrum for Fraser syndrome: Identification of a novel heterozygous deletion in FRAS1
Julia Hoefele et al.
GENE (2013)
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
Minoli A. Perera et al.
LANCET (2013)
Chromosome 4q deletion syndrome: Narrowing the cardiovascular critical region to 4q32.2-q34.3
Wenbo Xu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
Genotype-Phenotype Analysis of 4q Deletion Syndrome: Proposal of a Critical Region
Eugen-Matthias Strehle et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
Effect of oral diuretics on chronic warfarin therapy: a retrospective study
Heather D. Edwards et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Warfarin pharmacogenetics: challenges and opportunities for clinical translation
Nita A. Limdi
FRONTIERS IN PHARMACOLOGY (2012)
Cardiovascular Pharmacogenomics
Dan M. Roden et al.
CIRCULATION RESEARCH (2011)
Alternative splicing: good and bad effects of translationally silent substitutions
M. Raponi et al.
FEBS JOURNAL (2010)
Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese
Pei-Chieng Cha et al.
HUMAN MOLECULAR GENETICS (2010)
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
Fumihiko Takeuchi et al.
PLOS GENETICS (2009)
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Gregory M. Cooper et al.
BLOOD (2008)
Ethnic differences in cardiovascular drug response potential contribution of pharmacogenetics
Julie A. Johnson
CIRCULATION (2008)
VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans
Nita A. Limdi et al.
PHARMACOGENOMICS (2008)
Warfarin: An old drug but still interesting
Julie A. Johnson
PHARMACOTHERAPY (2008)
Inhibitory effects of angiotensin receptor Blockers on CYP2C9 activity in human liver Microsomes
Emi Kamiyama et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Systematic overview of warfarin and its drug and food interactions
AM Holbrook et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Role of dietary vitamin K intake in chronic oral anticoagulation: Prospective evidence from observational and randomized protocols
V Franco et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Genomic variants in exons and introns: identifying the splicing spoilers
F Pagani et al.
NATURE REVIEWS GENETICS (2004)
The medical management of valvar heart disease
NA Boon et al.
HEART (2002)
Nkx2.5 and nkx2.6, homologs of Drosophila tinman, are required for development of the pharynx
M Tanaka et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
